HIV and COINFECTIONS. 3rd ICONA FOUNDATION MEETING. Fondazione Icona S C I E N T I F I C P R O G R A M M E

Dimensione: px

Iniziare la visualizzazioe della pagina:

Download "HIV and COINFECTIONS. 3rd ICONA FOUNDATION MEETING. Fondazione Icona S C I E N T I F I C P R O G R A M M E"

Corinna Bassi
7 anni fa
Visualizzazioni

1 S C I E N T I F I C P R O G R A M M E HIV and COINFECTIONS Scientific Coordinators Andrea Antinori Antonella Castagna Francesca Ceccherini-Silberstein Alessandro Cozzi-Lepri Antonella d Arminio Monforte Enrico Girardi Sergio Lo Caputo Cristina Mussini Massimo Puoti ROME January 26-27, 2017 Auditorium Via Veneto Italian Cohort I. C O. N A. Naive Antiretrovirals Fondazione Icona I T A L I A N C O H O R T N A I V E A N T I R E T R O V I R A L S Conceived by Professor Mauro Moroni I. C O. N A. HEPA Hepatitis Icona Cohort

2 HIV and COINFECTIONS ICONA FOUNDATION STUDY GROUP Board of Directors A. d'arminio Monforte (President), A. Antinori, A. Castagna, F. Castelli, R. Cauda, G. Di Perri, M. Galli, R. Iardino, G. Ippolito, A. Lazzarin, G.M. Marchetti, C.F. Perno, G. Rezza, F. von Schlösser, P. Viale Presidential Committee A. Antinori, A. d'arminio Monforte, G. Ippolito, A. Lazzarin, C.F. Perno Scientific Secretary A. Antinori, A. d'arminio Monforte, A. Castagna, F. Ceccherini-Silberstein, A. Cozzi-Lepri, E. Girardi, S. Lo Caputo, C. Mussini, M. Puoti Scientific Committee A. Ammassari, M. Andreoni, A. Antinori, A. d'arminio Monforte, C. Balotta, A. Bandera, P. Bonfanti, S. Bonora, M. Borderi, A. Calcagno, L. Calza, M.R. Capobianchi, A. Castagna, F. Ceccherini-Silberstein, A. Cingolani, P. Cinque, A. Cozzi-Lepri, A. De Luca, A. Di Biagio, N. Gianotti, E. Girardi, A. Gori, G. Guaraldi, G. Lapadula, M. Lichtner, S. Lo Caputo, G. Madeddu, F. Maggiolo, G. Marchetti, S. Marcotullio, L. Monno, C. Mussini, S. Nozza, M. Puoti, E. Quiros Roldan, R. Rossotti, S. Rusconi, M. Santoro, A. Saracino, M. Zaccarelli Statistical and Monitoring Team A. Cozzi-Lepri, I. Fanti, L. Galli, P. Lorenzini, A. Rodano, M. Shanyinde, A. Tavelli Biological Bank INMI F. Carletti, S. Carrara, A. Di Caro, S. Graziano, F. Petrone, G. Prota, S. Quartu, S. Truffa

3 PRG_ICONA_DEFIN_Layout 1 20/01/ Pagina 4 SFACULTY CIENTIFIC P RMassimo O GofAndreoni RTorAVergata, MM E University Rome Maria Rosaria Iardino NPS Italia Onlus, Milan Gioacchino Angarano Giuseppe Ippolito University Hospital of Bari Andrea Antinori Adriano Lazzarin San Raffaele Hospital, Milan Stefania Carrara Sergio Lo Caputo University Hospital of Bari Antonella Castagna Patrizia Lorenzini San Raffaele Hospital, Milan IRCCS INMI Lazzaro Spallanzani, Rome Francesco Castelli University of Brescia Franco Maggiolo Roberto Cauda ASST Papa Giovanni XXIII, Bergamo Catholic University, Rome Giulia Marchetti Francesca Ceccherini-Silberstein University of Tor Vergata, Rome ASST S. Paolo and Carlo, San Paolo Hospital, Antonella Cingolani Simone Marcotullio Catholic University, Rome NADIR Onlus, Rome Alessandro Cozzi-Lepri Simona Montilla Royal Free & University College Medical School, University College of London UK AIFA Agenzia Italiana del Farmaco, Rome Cristina Mussini Davide Croce Carlo Cattaneo University LIUC, Castellanza VA University Hospital of Modena and Reggio Emilia, Modena Antonella d Arminio Monforte Carlo Federico Perno ASST S. Paolo and Carlo, San Paolo Hospital, University of Tor Vergata, Rome Carmela Pinnetti Andrea De Luca University Hospital of Siena Massimo Puoti Antonio Di Biagio Niguarda Ca Granda Hospital, Milan IRCCS AOU San Martino-IST, Genoa Stefano Rusconi Iuri Fanti Catholic University, Rome ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Massimo Galli Annalisa Saracino ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University Hospital of Bari Milensu Shanyinde Ivan Gardini EpaC Onlus, Vimercate MB Royal Free & University College Medical School, University College of London UK Enrico Girardi Gloria Taliani Sapienza University, Rome Andrea Gori Alessandro Tavelli San Gerardo Hospital, o-bicocca, Monza Giovanni Guaraldi University Hospital of Modena and Reggio Emilia, Modena ASST S. Paolo and Carlo, San Paolo Hospital, Mauro Zaccarelli

4 HIV and COINFECTIONS Registration Thursday, January 26, Introduction: rationale and aims of the third ICONA Meeting A. Antinori, A. d Arminio Monforte, M. Puoti Round Table Chairs: A. Antinori, F. Ceccherini-Silberstein Coinfection HIV-HCV: a public health problem and available resources Participants: D. Croce, A. d Arminio Monforte, I. Gardini, M.R. Iardino, S. Marcotullio, S. Montilla, M. Puoti Lunch Main Lectures Chair: F. Castelli HIV therapy: what s new? M. Andreoni Special communication A survey on HIV/HCV Italian people: the denial of DAAs therapy S. Marcotullio

5 S C I E N T I F I C P R O G R A M M E Session 1 ICONA and HepaICONA research in HIV and HIV-HCV coinfection Chairs: M. Galli, A. Lazzarin ART use and risk of ALT elevation in HIV/HCV co-infected patients M. Shanyinde Multiple lines of antiretroviral therapy in relation to HCV co-infections G. Marchetti Durability and tolerability of first-line combination including RAL or ATV/r or DRV/r P. Lorenzini Prescription pattern and determinants of Dolutegravir use in naïve HIV-infected patients S. Lo Caputo Survival in HIV+ patients with lymphoma compared to general population A. Cingolani Impact of social determinants on ART A. Saracino Discussion Coffee break Main Lectures Analyzing current trends of HIV epidemic: the role of cohort studies E. Girardi The management of DAA failure C.F. Perno Session 2 ICONA and HepaICONA research in HIV and HIV-HCV coinfection Chairs: G. Angarano, C.F. Perno Reducing Pill Burden vs. Drug Burden as Strategy of ART Simplification M. Zaccarelli CD4/CD8 Ratio in Patients switching Triple vs Dual/Mono Therapy C. Mussini HIV-positive subjects treated with the STR cobicistat, elvitegravir, emtricitabine and tenofovir when ART-naïve in clinical practice A. Cozzi-Lepri Discussion Final considerations A. Antinori, A. d Arminio Monforte, M. Puoti

6 HIV and COINFECTIONS Friday, January 27, ICONA and HepaICONA research projects Chairs: R. Cauda, G. Ippolito Non-Interventional Observational Study in HIV positive patients from Italy, receiving emtricitabine/tenofovir alafenamide based regimens: correlation of safety and efficacy with clinical and immune virologic parameters and PROs C. Pinnetti Patient-reported outcomes measurement in the ICONA study A. Cingolani Parallel Workshops on data from ICONA and HepaICONA reports Sala A Workshop 1 Epidemiology A. Cingolani, E. Girardi, A. Saracino Auditorium Workshop 2 Coinfections A. De Luca, M. Puoti, G. Taliani Auditorium Workshop 3 HIV Therapy A. Di Biagio, F. Maggiolo, S. Rusconi Sala A Workshop 4 HIV Comorbidities A. Gori, G. Guaraldi, G. Marchetti Wrap-up from parallel Workshops Chairs: A. Castagna, C. Mussini Workshop 1 Epidemiology A. Cingolani, E. Girardi, A. Saracino Workshop 2 Coinfections A. De Luca, M. Puoti, G. Taliani Workshop 3 HIV Therapy A. Di Biagio, F. Maggiolo, S. Rusconi Workshop 4 HIV Comorbidities A. Gori, G. Guaraldi, G. Marchetti Open discussion among ICONA and HepaICONA Centres Facilitators: S. Carrara, I. Fanti, A. Tavelli Final considerations A. Antinori, A. d Arminio Monforte, M. Puoti Lunch

7 S C I E N T I F I C P R O G R A M M E GENERAL INFORMATION Venue Auditorium Via Veneto Via Veneto, Rome I Crediti ECM La Commissione Nazionale per la Formazione Continua in Medicina ha assegnato n. 11 crediti formativi al Meeting (N. ECM ) per Biologi, Farmacisti ospedalieri e territoriali e Medici Specialisti in Malattie Infettive, Microbiologia e Virologia, Igiene, Epidemiologia e Sanità Pubblica, Direzione Medica di Presidio Ospedaliero, Allergologia e Immunologia Clinica, Medicina Interna e Gastroenterologia. L assegnazione dei crediti formativi è subordinata alla presenza al 90% dei lavori e alla corretta compilazione di almeno il 75% delle domande proposte all interno del questionario di valutazione finale. È inoltre obbligatoria la rilevazione delle presenze e la compilazione del questionario di valutazione e di gradimento dell evento formativo. CME Provider and Organizing Secretariat Effetti Srl Via Gallarate, Milan, Italy Phone Fax Mail: effetti@effetti.it -

8 HIV and COINFECTIONS THANKS TO THE SPONSORS The ICONA Foundation, the Scientific Coordinators and the CME Provider wish to thank for support given in the form of unrestricted educational grants the following Companies: PLATINUM SPONSOR SILVER SPONSORS

Documenti analoghi

Face-to-Face. HIV and COINFECTIONS. 2nd INTERCOHORTS MEETING S C I E N T I F I C P R O G R A M M E. Fondazione Icona

Face-to-Face. HIV and COINFECTIONS. 2nd INTERCOHORTS MEETING S C I E N T I F I C P R O G R A M M E. Fondazione Icona S C I E N T I F I C P R O G R A M M E Face-to-Face HIV and COINFECTIONS 2nd INTERCOHORTS MEETING Scientific Coordinators: Andrea Antinori Antonella d Arminio Monforte Antonella Castagna Francesca Ceccherini-Silberstein